Express Pharma

SEPTEMBER 3, 2023

Even as the National Medical Commission Registered Medical Practitioner (Professional Conduct) Regulations, 2023, is held in abeyance till further notice, it has strengthened the call for quality medicines. Let us examine the possible impact on the pharma sector. Speaking for most doctors, the Indian Medical Association (IMA) compared the National Medical Commission’s (NMC) push towards promotion of generics as “running trains without tracks’’, reasoning that not all generic medicines are of the

Generic Medicine 110

Generic Medicine 110

Med Ed 101

SEPTEMBER 3, 2023

Failure to thrive in the elderly is a common syndrome I have encountered in my work as a clinical pharmacist working with geriatric patients. The National Institute of Aging describes failure to thrive (FTT) as a “syndrome of weight loss, decreased appetite and poor nutrition, and inactivity, often accompanied by dehydration, depressive symptoms, impaired immune […] The post Top 5 Drugs That Contribute To Failure To Thrive In The Elderly appeared first on Med Ed 101.

Immunity 98

Immunity Immunization 98

Express Pharma

SEPTEMBER 3, 2023

Biocon recently announced that its step-down, wholly-owned subsidiary, Biocon Generics has acquired Eywa Pharma’s oral solid dosage manufacturing facility, located in Cranbury, New Jersey, US, effective September 1, 2023. A company statement informed, “The facility is acquired for a total consideration of $7.7 million. As part of the acquisition, the existing workforce of the facility will transition to Biocon Generics.

Dosage 110

Dosage 110

PharmExec

SEPTEMBER 3, 2023

One of the most special things about Pharmaceutical Executive®, in my opinion, is when people share their stories—where they came from; how their upbringing or education or background impacted their desire to work in pharma; any personal ties to their work, such as finding new treatments in a specific disease state due to a loved one having been impacted by that same disease; and just generally sharing their passion for their work.

97

97

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Drug Patent Watch

SEPTEMBER 3, 2023

QUTENZA (capsaicin) Averitas Patent: 10,869,827 Expiration: Sep 5, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit… The post Drug Patent Expirations for the Week of September 3, 2023 appeared first on DrugPatentWatch - Make Better Decisions.

59

59

Pharmacy Joe

SEPTEMBER 3, 2023

In this episode, I’ll discuss whether apixaban’s loading dose duration should ever be shortened. Episode 849: Should apixaban’s loading dose duration ever be shortened? Subscribe on iTunes , Android , or Stitcher A common clinical scenario in hospitals is the following: You have a patient with DVT or PE that has been on a therapeutic heparin infusion for several days, the physician wants to switch the patient to apixaban and asks you if the 7 day period of 10 mg po bid should be redu

Labelling 52

Labelling Hospitals Inpatient 52

Drug Patent Watch

SEPTEMBER 3, 2023

This chart shows the pharmaceutical companies with the most patents in Peru. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is… The post Which pharmaceutical companies have the most drug patents in Peru? appeared first on DrugPatentWatch - Make Better Decisions.

Pharmaceutical Companies 59

Pharmaceutical Companies Pharmaceutical Companies 59

EMCrit Project

SEPTEMBER 3, 2023

In many countries, pulmonary and critical care are commonly bundled together. Consequently, a single person will often be responsible for both inpatient ICU management as well as inpatient pulmonary consultation. Honestly, I have some doubts about whether this is an ideal system. As both pulmonology and critical care medicine become increasingly complex, it's becoming impossible […] EMCrit Project by Josh Farkas.

Inpatient 134

Inpatient Hospitals 134